Work with thought leaders and academic experts in genetics clinical

8 years of science and engineering experience integrating multi-omics data to identify biomarkers for cancer studies. Seeking to apply data analytics expertise to develop new diagnosis and treatment strategies.

Jeffrey Townsend is a Professor of Organismic and Evolutionary Biology at Yale University. He received his Ph.D. from Harvard University in 2002 and his Sc.B. from Brown University in 1994. He has been a teacher at St. Ann's School and an Assistant Professor at the University of Connecticut. He is currently the Elihu Professor of Biostatistics at Yale University.

Katie Barr is a bioinformatician with a strong background in computer science. She received her Ph.D in Quantum Information from the University of Leeds in 2013. She also holds an MSc in Mathematical logic and the theory of computation from the University of Manchester, and a BSc in Physics and Philosophy with study in Continental Europe from the University of Bristol. Katie has extensive experience working in the fields of bioinformatics and software development. She has worked as a scientific programmer at the Earlham Institute, a postdoctoral bioinformatician in the Nanomedicine group at the University of Manchester, and is now an Associate Principal Scientist in Bioinformatics at Kromek. Katie is passionate about using her knowledge and skills to improve the lives of others and she is dedicated to the advancement of science and technology. She believes in the power of collaboration and works to create meaningful partnerships between industry and academia.

Dr. Justin P. Whalley was educated in the UK (M.Sci. Mathematics, University of Bristol) and France (Ph.D. Bioinformatics, University of Évry). He moved to Spain to work as a postdoc at the National Center for Genomic Analysis (CNAG). During his time there, he ran the Quality Control working group for the Pan-Cancer Analysis of Whole Genomes project to assess the data coming in and reduce batch effects. This involved collaboration with researchers from the Broad Institute of MIT and Harvard, the German Cancer Research Center and the Wellcome Sanger Institute in the UK. He returned to the UK to work as a [Senior Bioinformatician at the University of Oxford](https://www.well.ox.ac.uk/people/jpw/). His time there coincided with the global pandemic and he was deeply involved in the COvid-19 Multi-omics Blood ATlas (COMBAT) consortium as the lead for the Integration (Tensor) working group. Dr. Whalley became a member of the [faculty of the Chicago Medical School at Rosalind Franklin University of Medicine and Science](https://www.rosalindfranklin.edu/academics/faculty/justin-p-whalley/) in January 2023.

Edoardo Airoldi is a Professor in the Department of Machine Learning at Temple University. He is also the Director of the Center for Machine Learning and Health. He is a world-renowned expert in the fields of machine learning and artificial intelligence, with a focus on applications to health. Airoldi is a member of the prestigious Association for the Advancement of Artificial Intelligence (AAAI) and the International Machine Learning Society (IMLS). He has published over 200 papers in leading journals and conferences, and his work has been covered by various media outlets including The New York Times, The Wall Street Journal, The Economist, and Wired.

Luke Connelly is Professor of Health Economics at the Centre for the Business and Economics of Health. He also holds a Professorial appointment (part-time) at The University of Bologna, to which he was appointed in 2017 via the Italian “Direct Call” ([link](https://www.unibo.it/sitoweb/luke.connelly/en)) process. In 2019 he was appointed as Honorary Professor at The University of Sydney. His main interests are in health economics and insurance economics and the effects of institutions (including legal constructs) on incentives and behaviour. He has also worked in other fields of applied microeconomics, including education economics and transport economics. His publications include papers in *Review of Income and Wealth*, *Health Economics*, *Journal of Health Economics*, *Journal of Risk and Insurance*, *Geneva Papers on Risk and Insurance*, *Accident Analysis and Prevention*, *Journal of Law and Medicine*, *Journal of Clinical Epidemiology*, *European Journal of Health Economics*, *International Journal of Health Economics and Finance*, *Social Science and Medicine*, *Economic Papers*, *Economic Analysis and Policy*, *Journal of Transport Economics and Policy*, *Labour Economics*, *Economics and Human Biology* as well as in a range of clinical journals, including *Lancet*. Luke has served on a number of public committees including the Medical Services Advisory Committee (MSAC), which advises the Australian Minister for Health on the safety, efficacy, effectiveness, and cost-effectiveness of new and extant listings on Australia's Medicare Benefits Schedule. He has extensive service on other public committees and taskforces as well as extensive teaching and consulting engagements with industry. Over his career he has been a chief investigator on research grants and contracts totalling more than $67m. He is a member of the Editorial Boards of European Journal of Health Economics and the International Journal on Environmental Research and Public Health. He is a member of the International Health Economics Association's Arrow Awards Committee, which awards an annual prize in honour of Nobel Laureate Kenneth Arrow for the best paper in the field. He is currently Guest Editor (with Christophe Courbage) on a Special Issue of the Geneva Papers on Risk and Insurance on Insurance and Emerging Health Risks. His current research interests include health service innovations to improve the health of people with chronic kidney disease(CKD). Ongoing interests include the economics of disability and insurance, compensable injury compensation schemes, and the determinants of health. Luke enjoys and has considerable experience teaching economics and health economics at both the graduate and undergraduate levels. In 2014 he was awarded the School of Economics Distinguished Teaching Award for his teaching on UQ's Master of Health Economics Program. In July 2016 and July 2019 he also taught summer schools in Health Economics and the Economics of Insurance at The University of Lucerne, Switzerland. Over the past 10 years he has been a chief investigator on grants totalling more than $70m.

I have a decade-long expertise in **next generation sequencing,** **molecular biology, genetics, cell biology** and bioinformatic analysis. I have expertise in designing, optimizing, improvising, and troubleshooting molecular biology experiments through my postdoc at Harvard, Carleton, and PhD from IISER. I have experience of **developing and optimizing new experiments** in next gen seq as I have designed new experiments to do the first silk moth wing ChIP seq, a cell-type specific RNA seq at Harvard and in situs for salamanders at a primarily fossil lab in Carleton University.

My core interests lie in understanding how children and adolescents perceive and interpret social signals and how emerging functional specificity of the developing brain supports this process. My approach primarily involves using the face processing system as a model domain. Faces are dynamic stimuli from which we extract many different kinds of information (e.g., gender, age, emotional state, mate potential, social status, trustworthiness, intentions, “person knowledge”). All of these processes must be executed accurately and rapidly for many faces over the course of a single day, making face processing among the most taxing perceptual challenges confronted by people in their day-to-day life. Given that faces are also the pre-eminent social signal, studying developmental changes in the behavioral and brain basis of face processing in typically developing individuals and in those affected by social-emotional disorders may index a core set of developmental changes within the broader social information processing system. I employ converging methodologies, including functional (fMRI) and structural magnetic resonance, and diffusion tensor imaging (DTI) along with detailed behavioral paradigms in both typically developing populations and those with developmental disorders to examine development from early childhood to adulthood.

Marie Mooney, PhD is an Assistant Professor of Bioinformatics at the University of North Florida. She holds a PhD in Cell and Molecular Genetics from the Van Andel Research Institute, a MS in Biomedical Engineering from the University of Cincinnati, and a BS in Bioinformatics, from Michigan Technological University. Prior to her current role, she served as a Senior Postdoctoral Associate at Lurie Children's Hospital, A T32 Postdoctoral Scholar In Applied Genomics and Precision Medicine at Duke University, a Research Associate at Michigan State University. Her research focuses on integrative and translational approaches to repurpose therapeutics for use in rare congenital disorders. Her laboratory uses zebrafish as a genetic model organism to generate and test bioinformatics-driven hypotheses.

## Scientist Genomics I have my major, MSc, and PhD degrees in biology, human, and medical genetics. I have hands-on experience in a variety of molecular biology and genetic techniques and have worked on NGS library preparation, scRNA-seq, and data analysis. As shown in my resume (I can also send my CV if needed), in addition to genomic experiments, I have worked on other omic profiling such as epigenome (DNA methylation), proteomics, and transcriptomics in a variety of samples including human cells and animal tissues. With more than 20 years of work experience, I have worked in hospital, academic, and biotech settings and proactively had to take a strategic thinking and problem-solving approach. Thus, I am adaptable to changing directions and methods, and eager to work in a dynamic, fast-paced research and product development environment. I also have multiple experiences managing multicenter and international collaborations and managing multiple priorities in a cross-functional team. I personally give fundamental value to diversity and building new connections and collaborations, and learning from diverse team members. Continuous learning and teamwork are my core values. There are other examples of my attention to detail, optimizing and troubleshooting techniques and experiments in molecular biology, genomics, and NGS panel design. As an example of my resilience, in a collaboration between CZ Biohub and the Stanford Pediatrics Department, I had to pilot a split-seq and combinatorial barcoding NGS method for newborn lung samples from library preparation up to scRNA-seq analysis. With a strong background in genomics and biology and expertise in the wet lab and data analysis, I could be a valuable asset to the Product Development teams where they need someone to lead and advance genomics research and NGS technology development, outreach, and shaping the future of genomics research, especially in clinical genetics and medical genomics. As I pursue a multidisciplinary collaboration in my scientific rationale, particularly, I am eager to extend my dedication to commercialization and envision the genomics product for financial gain and bringing value to the market. In summary, I have expertise and am eager to continue to design, conduct, and optimize new biological and genomics experiments and elucidate underlying mechanisms. I have more than 20 years of direct work experience in clinical research, both within hospital settings and in functional genomics labs. These roles required me to perform a variety of monitoring tasks depending on the context. This included monitoring lab and patient data, as well as monitoring various types of data such as clinical, molecular, and omics data, including genomics and proteomics. I have experience in developing IVD tests such as NGS panels and Polygenic Risk Scores (PRS) for genetic diseases.

Dr. Bala brings a wealth of knowledge and expertise to his role as an Associate Professor in Clinical Pharmacy at the School of Pharmaceutical Sciences, USM. He has a proven track record of success in his field, having held key leadership positions such as Director at the Malaysian National Poison Centre and Program Chairman (Clinical Pharmacy) at the School of Pharmaceutical Sciences, USM. He holds a Bachelor of Pharmacy from USM and a PhD from Brighton and Sussex Medical School, UK. Additionally, he has been appointed as Visiting Senior Lecturer at King's College London and as a Fellow of the WHO Collaborating Centre for Drug Information at the National Poison Centre. <br> Bala's research focuses on the areas of clinical pharmacy practice and medication safety, as well as geriatric pharmacy. He has published more than 50 peer-reviewed journal articles/abstracts and has been invited as a guest speaker at numerous international and domestic scientific events. He is an experienced internal and external examiner for over 40 PhD and Master thesis and has actively reviewed manuscripts for international academic journals. Bala's teaching activities encompass both undergraduate and postgraduate-level instruction, and he has supervised the research of numerous postgraduate students. He is committed to curriculum development and has implemented innovative and interactive teaching methods to improve student learning outcomes. He has successfully graduated 24 students, including 4 PhDs, 4 MSc, and 16 Master in Clinical Pharmacy. He is dedicated to producing sustainable pharmacy education and closing the knowledge transfer gap for students. If you're interested in Clinical Pharmacy, Geriatric pharmacy, Medication Safety, Research and Education, feel free to connect and exchange ideas.

Instrumental in leading the development of Ascribe technology from start-up to successful execution. Skilled in identifying and capitalizing on emerging technologies and executing R&D strategic objectives to accelerate the product development process and increase customer centricity across different markets. Excel in overseeing cross-function projects with substantial R&D budgets to transform scientific discoveries into market-ready products. Tech leader and inventor with solid business acumen, holding patents for successful start-up and market-ready products. Expert at developing high-performing teams for commercializing new, differentiated, and disruptive products. Experienced researcher with effective communication and interpersonal skills; known for expanding business by collaborating with industry leaders, academic researchers, and contract research organizations. Passionate about driving innovation and delivering impactful results for business growth and market expansion. As a Ph.D. in Biochemistry, Molecular Biology, and Plant Science, I bring a strong background and expertise in agriculture and biopharmaceutical research. But more than that, I am driven by a deep passion for advancing Agtech, Foodtech, and Biotech solutions. My mission is to harness the power of nature to create sustainable and effective products that can enhance plant and human health.

I am a research scientist at Salk Institute for Biological Studies, where I apply my expertise in molecular biology, genetic engineering, and bioinformatics to address fundamental questions in development. I have over six years of experience in conducting cutting-edge research in plant meristems, stem cells, epigenetics, and genome-wide association studies (GWAS).